Rats with sarcoma M-1 were exposed to high dose rate irradiation with 169Yb source. In 25 days after introduction of a trocar with sealed capsule with 169Yb source into the tumor, complete tumor regression was observed in 70% animals. The results suggest feasibility of using 169Yb source for high-dose rate brachytherapy and development of the personalized medicine approaches.
Similar content being viewed by others
References
Kaprin AD, Biryukov VA, Karyakin OB, Galkin VN, Ivanov SA, Obukhov AA, Borysheva NB, Lepilina OG, Gemenetskaya YuV, Gulidov IA. The use of high-power brachytherapy with Ir-192 in the treatment of prostate cancer. Rus. Med. Zh. 2017;25(8):492-495. Russian.
Kaprin AD, Galkin VN, Zhavoronkov LP, Ivanov VK, Ivanov SA, Romanko YuS. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiatsiya Risk. 2017;26(2):26-40. Russian.
Ulianenko S, Lychagin А, Stepanenko V, Potetnya V, Koryakin S, Brovin А, Beketov E, Dubov D, Tishkin A, Kudrin А. Absorbed dose formation in phantom from high dose microsource of Ytterbium-169. Med. Fizika. 2011;(2):31-38. Russian.
Ulianenko S, Potetnya V, Koryakin S, Isaeva E, Lychagin A, Beketov E, Brovin А. Phantom аnd radiobiological studies of high intensity Ytterbium-169 radiation. Med. Fizika. 2011;(3):40-46. Russian.
Brenner DJ. Radiation Biology in Brachytherapy. J. Surg. Oncol. 1997;65(1):66-70.
Currier B, Munro JJ 3rd, Medich DC. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection. Med. Phys. 2013;40(8). ID 080701. doi: 10.1118/1.4812675.
Implementation of High Dose Rate Brachytherapy in Limited Resource Settings. IAEA, 2015.
Laprise-Pelletier M, Lagueux J, Côté MF, LaGrange T, Fortin MA. Low-dose prostate cancer brachytherapy with radioactive palladium-gold nanoparticles. Adv. Healthc. Mater. 2017;6(4). doi: 10.1002/adhm.201601120.
Leonard KL, DiPetrillo TA, Munro JJ, Wazer DE. A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer. Brachytherapy. 2011;10(2):163-169.
Loft SM, Coles IP, Dale RG. The potential of ytterbium-169 in brachytherapy: a brief physical and radiobiological assessment. Br. J. Radiol. 1992;65:252-257.
Radionuclide Transformations — Energy and Intensity of Emissions. ICRP Ann. ICRP 11-13. 1983.
Wilkinson DA. High dose rate (HDR) brachytherapy quality assurance: a practical guide. Biomed. Imaging Interv. J. 2006;2(2):e34. doi: 10.2349/biij.2.2.e34.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 1, pp. 91-93, January, 2019
Rights and permissions
About this article
Cite this article
Ulyanenko, S.E., Koryakin, S.N., Lychagin, A.A. et al. Evaluation of Antitumor Efficiency of High Intensity Radiation 169Yb Source on Experimental Sarcoma M-1. Bull Exp Biol Med 167, 84–86 (2019). https://doi.org/10.1007/s10517-019-04466-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04466-4